Back
Galera Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
15
GRTX
Galera Therapeutics
Last Price:
$0.03
Seasonality Move:
-17.09%
Sell
31
NBY
NovaBay Pharmaceuticals
Last Price:
$0.65
Seasonality Move:
-16.45%
Sell
15
Galera Therapeutics (GRTX)
is a Sell
Is Galera Therapeutics a Buy, Sell or Hold?
-
The current Galera Therapeutics [GRTX] share price is $0.03. The Score for GRTX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
GRTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.66. The Score for NBY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRTX Stock Price Chart
What is Galera Therapeutics's stock price today?
-
The Galera Therapeutics share price today is $0.03The current trend is relatively stagnant and GRTX is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
GRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 44.99 | Sell |
Chaikin Money Flow: | -24940 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.03 - 0.03) | Sell |
Bollinger Bands (100): | (0.02 - 0.04) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 58.55 | Buy |
Chaikin Money Flow: | -6749 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.59 - 0.67) | Buy |
Bollinger Bands (100): | (0.55 - 0.63) | Buy |
GRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.03 | Sell |
20-day SMA: | 0.03 | Sell |
50-day SMA: | 0.03 | Sell |
200-day SMA: | 0.04 | Sell |
8-day EMA: | 0.02 | Buy |
20-day EMA: | 0.02 | Buy |
50-day EMA: | 0.01 | Buy |
200-day EMA: | 0 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.63 | Buy |
50-day SMA: | 0.6 | Buy |
200-day SMA: | 0.62 | Buy |
8-day EMA: | 0.59 | Buy |
20-day EMA: | 0.39 | Buy |
50-day EMA: | 0.2 | Buy |
200-day EMA: | 0.06 | Buy |
Galera Therapeutics Earnings Growth & GRTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Galera Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |